TGFB1 and interstitial lung disease: Pathway activity profiling revealed that Mono1, Mono2, and Mono5 in ASS-ILD were enriched in innate and adaptive immunity-related pathways, including IL-17, JAK-STAT, NF-κB, TGF-β, and TNF signaling (Figure 5D).